These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3061756)

  • 41. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
    Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
    Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB; Cherney DZ; Curtis JR; Dekker MG; Scholey JW; Miller JA
    J Am Soc Nephrol; 2006 Jun; 17(6):1703-9. PubMed ID: 16672313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.
    Tonneijck L; Muskiet MH; Smits MM; van Bommel EJ; Heerspink HJ; van Raalte DH; Joles JA
    J Am Soc Nephrol; 2017 Apr; 28(4):1023-1039. PubMed ID: 28143897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible participation of a prostaglandin E1 analogue in the aggravation of diabetic nephropathy.
    Aoki Y; Yanagisawa Y; Oguchi H; Yazaki K; Furuta S
    Diabetes Res Clin Pract; 1992 Jun; 16(3):233-8. PubMed ID: 1425144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetic nephropathy. Metabolic versus hemodynamic considerations.
    Hostetter TH
    Diabetes Care; 1992 Sep; 15(9):1205-15. PubMed ID: 1396017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G; Repetto M; Calvi C; Ciabattoni M; Rossi C; Robaudo C
    Nephrol Dial Transplant; 1998; 13 Suppl 8():11-5. PubMed ID: 9870419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy.
    Mathiesen ER; Hommel E; Olsen UB; Parving HH
    Diabet Med; 1988 Mar; 5(2):145-9. PubMed ID: 2964980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A; Earle KA; Rodemann HP; Viberti GC
    Diabetologia; 1997 Feb; 40(2):244-6. PubMed ID: 9049488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diabetic microangiopathy].
    Standl R
    Z Gesamte Inn Med; 1993 Mar; 48(3):140-9. PubMed ID: 8475638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients.
    New JP; Marshall SM; Bilous RW
    Diabetologia; 1998 Feb; 41(2):206-11. PubMed ID: 9498655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study.
    Amin R; Turner C; van Aken S; Bahu TK; Watts A; Lindsell DR; Dalton RN; Dunger DB
    Kidney Int; 2005 Oct; 68(4):1740-9. PubMed ID: 16164650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal function changes in hypertensive patients with non-insulin- dependent diabetes mellitus.
    Rius F; Pizarro E; Castells I; Salinas I; Sanmartí A; Romero R
    Kidney Int Suppl; 1996 Jun; 55():S88-90. PubMed ID: 8743520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microalbuminuria. Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients.
    Kouri TT; Viikari JS; Mattila KS; Irjala KM
    Diabetes Care; 1991 Jul; 14(7):591-3. PubMed ID: 1914800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic kidney disease in Pima Indians.
    Nelson RG; Knowler WC; Pettitt DJ; Saad MF; Bennett PH
    Diabetes Care; 1993 Jan; 16(1):335-41. PubMed ID: 8422805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.
    Sällström J; Carlsson PO; Fredholm BB; Larsson E; Persson AE; Palm F
    Acta Physiol (Oxf); 2007 Jul; 190(3):253-9. PubMed ID: 17581137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-insulin-dependent diabetes mellitus, nephropathy, and the renin system.
    Hollenberg NK
    J Hypertens Suppl; 1997 Dec; 15(7):S7-13. PubMed ID: 9532515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.